Immunitybio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $51,240 | $44,206 | $38,285 | $32,061 |
Gross Profit | 50,942 | 43,968 | 34,038 | 27,933 |
EBITDA | -221,583 | -599,947 | -31,036 | -35,774 |
EBIT | -230,370 | -604,327 | -34,901 | -39,725 |
Net Income | -230,378 | -632,782 | -61,944 | -67,253 |
Net Change In Cash | 51,240 | 44,206 | 38,285 | 32,061 |
Free Cash Flow | -147,145 | -77,146 | -71,653 | -69,682 |
Cash | 75,670 | 205,194 | 88,334 | 60,241 |
Basic Shares | 1,050,070 | 1,026,874 | 989,679 | 946,601 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $113,288 | $14,745 | $622 | $240 |
Gross Profit | 112,535 | 14,745 | 622 | 240 |
EBITDA | -223,557 | -264,433 | -478,663 | -351,881 |
EBIT | -239,082 | -281,987 | -497,175 | -370,141 |
Net Income | -351,398 | -413,564 | -583,196 | -416,567 |
Net Change In Cash | 113,288 | 14,745 | 622 | 240 |
Cost of Revenue | -76,599 | |||
Free Cash Flow | -308,782 | -398,124 | -397,341 | -415,671 |
Cash | 88,334 | 143,428 | 265,453 | 104,641 |
Basic Shares | 919,863 | 700,443 | 508,636 | 399,900 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | -$0.08 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.07 |